Korea Investment Partners is a prominent venture capital and private equity firm based in Seoul, South Korea, with over 30 years of experience in the investment sector. Founded in 1986, the firm focuses on supporting bold and innovative entrepreneurs across various industries, including biotechnology, healthcare, interactive content, media, consumer internet, financial technology, information and communication technology, digitalization, semiconductor, and industrial sectors. Korea Investment Partners has established a strong track record by investing in notable companies such as Kakao, Naver, YG Entertainment, Bodyfriend, and Didi Chuxing. The firm manages more than 20 venture and private equity funds, with total assets under management amounting to approximately $1.8 billion. In addition to its headquarters in Seoul, Korea Investment Partners has offices in Shanghai, Beijing, and Sunnyvale, allowing it to operate on a global scale.
Doers is an influencer commerce platform that offers several services for connecting influencers and companies.
At Home
Series A in 2025
AtHome is a home lifestyle solution company which solves the hidden problems for the customers.
Eastern Edition
Series A in 2025
Eastern Edition is a furniture brand that reinterprets traditional Korean aesthetics in a modern way.
HyperAccel
Series A in 2024
HyperAccel provides hardware solutions for developing AI applications.
Aldavar
Series A in 2024
ALDAVER provides incredibly realistic personalized surgical training models using innovative biopolymer materials that closely resemble human tissues and 3D printing technology.
Panmnesia
Series A in 2024
Panmnesia is a Korean chip startup. It is focused on developing intellectual property around a technology, which allows big data center operators to pool devices such as AI accelerator chips, processors, and memory.
Brave Company
Series A in 2024
Brave company is a wellness company that creates consumer goods brands such as chicken breast and diet convenience foods. Brave Company aims to revolutionize the world's everyday health by infiltrating the daily routines of exercising, eating, and enjoying together with creators.
Wello
Series A in 2024
Wello is a government business solution that offers a natural language processing-based business recommendation-application-management service.
Allround Doctors
Series A in 2024
Allround Doctors is a digital healthcare startup that develops digital medical devices for cancer patients.
CLAP
Series A in 2024
Clap is a performance management platform for the growth of people and businesses. The integrated growth platform connects employee goals, feedback, and performance and provides an optimal solution for the introduction of a regular performance management system and a powerful onboarding program.
Over The Hand
Series A in 2024
Over the Hand provides a virtual character of realism and energy via immersive technologies to provide new chances through diversified content.
LILLEM
Series A in 2024
LILLEM is a manufacturing company that engages in the research, development, and production of lithium secondary battery materials.
LabInCube
Series A in 2024
LabInCube develops inCube materials capable of selective drug release, sustained release, and supporting complex raw materials.
StealthMole
Series A in 2024
StealthMole is an AI-powered dark web intelligence firm that focuses on monitoring cyber dangers and detecting criminality.
The Grit
Series A in 2023
The Grit manufactures multi-use container and collection boxes.
Petpharma
Series A in 2023
Petpharma is an Operator of an e-commerce platform intended to provide veterinary medicines.
Indent
Series A in 2023
Indent is a provider of SPRAY, the Instagram affiliate marketing solution, for online shopping stores. It brings your customers' friends to your store and the average cost per this visit is only $1.
Thorough Future
Series A in 2023
Thorough Future specializes in the integration of advanced technology within the medical sector, focusing on enhancing diagnostic services in clinical medicine. The company leverages artificial intelligence and big data to offer intelligent diagnosis and predictive services for pathology images. This innovative approach aims to improve diagnostic accuracy and efficiency, particularly for cancer patients, by providing personalized treatment recommendations. Through its commitment to integrating cutting-edge technology into healthcare, Thorough Future seeks to transform the way medical diagnoses are conducted and treatments are tailored.
infludeo
Series A in 2023
infludeo is a fan membership platform that connects global Kpop fans with Kpop artists.
Xpanner
Series A in 2023
Xpanner is a developer of a cloud-based construction management platform that aims to enhance productivity, management efficiency, and safety within the construction industry. By integrating various construction technology products, Xpanner provides a unified solution that allows construction teams to access and manage data from multiple sources through a single point of entry. This approach fosters collaboration among stakeholders, leading to improved project outcomes and an average productivity improvement of 15%. The platform also emphasizes environmental, social, and governance (ESG) enhancements, making it a comprehensive tool for modern construction management.
CashWalk
Series A in 2023
CashWalk is an innovative app that encourages users to engage in physical activity by offering financial incentives for walking. The platform incorporates a unique pedometer feature that not only tracks users' steps but also allows them to earn rewards for their activity. In addition to promoting fitness, CashWalk provides health management solutions aimed at helping users manage chronic conditions such as hypertension, hyperlipidemia, and diabetes. By combining health benefits with monetary rewards, CashWalk aims to motivate individuals to lead healthier lifestyles while earning incentives for their efforts.
Indent
Series A in 2023
Indent is a provider of SPRAY, the Instagram affiliate marketing solution, for online shopping stores. It brings your customers' friends to your store and the average cost per this visit is only $1.
ENERZAi
Series A in 2023
ENERZAi is an artificial intelligence technology company based in Seoul, South Korea, that specializes in developing solutions for the oil and gas engineering sector. The company focuses on autonomous drilling systems, providing technology for supervising, monitoring, and controlling physical processes with real-time capabilities. In addition to this, ENERZAi offers services related to microcontroller units, central processing units, and application processors, facilitating AI applications in smart sensors, wearable devices, and robotics. Their technology aims to help clients transition from costly GPU instances, while optimizing model size, inference time, and operational costs.
Value of Space
Series A in 2022
Value of Space is a provider of real estate auto-assessment financial services, utilizing an AI-driven estimation platform. The company specializes in investment management for various types of real property, offering a multi-tier automatic valuation model. This model generates market value estimates by employing single parameter models, multiple linear models, and minimum variance adjustment models. Through its platform, Value of Space delivers comprehensive real estate information applicable to commercial, industrial, and residential properties, thereby assisting clients in making informed investment decisions.
Rgenta Therapeutics
Series A in 2022
Rgenta Therapeutics, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, specializing in the development of RNA-targeting medicines with a primary focus on oncology and neurological disorders. Founded in 2018, the company utilizes a proprietary platform that analyzes extensive genomic data to identify targetable RNA processing events. This platform enables the design of small-molecule compounds that modulate interactions among the spliceosome, regulatory proteins, and RNAs. By unlocking the therapeutic potential of previously undruggable targets, Rgenta aims to create oral, small-molecule therapies that address critical needs in human disease treatment, particularly in the realm of cancer.
XYZ
Series A in 2022
XYZ, Inc. is a service robot startup focused on integrating artificial intelligence into everyday life through innovative robotic solutions. The company specializes in developing various service robots aimed at automating retail and hospitality environments. Notable products include a barista robot for coffee preparation, an ice cream robot for serving desserts, and a food and beverage delivery robot designed to streamline customer service. XYZ has established collaborations with prominent brands such as Porsche Korea, Hyundai Motor Company, and Grand Walkerhill Hotel, showcasing its commitment to advancing unmanned technologies tailored to industry needs. By offering customizable robotic solutions, XYZ aims to enhance operational efficiency and improve customer experience in diverse settings.
S&E bio
Venture Round in 2022
S&E Bio is a biopharmaceutical company dedicated to developing cell therapies specifically designed to treat neurological disorders. The company focuses on creating safe and effective treatments using stem cell-derived extracellular vesicles. Its innovative approach targets various conditions, including acute stroke, moyamoya disease, chronic stroke, dementia, and cognitive disorders. By leveraging mesenchymal stem cell-derived therapeutics, S&E Bio aims to provide advanced treatment options for patients suffering from these challenging and often incurable diseases.
Tatum security
Series A in 2022
Tatum security provides cloud security software for businesses. All enterprise infrastructure environments are transitioning to the cloud, Enterprises need a flexible and secure form of security. Tatum security's Cloud Security Configuration Management (CSPM) technology helps companies build context-optimized cloud security. Enterprises use Tatum security's CSPM (Cloud Security Configuration Management) technology, You can build cloud security that is optimized for each situation.
Mobyus & Value Chain
Series A in 2022
Mobyus & Value Chain is a logistics automation solution company that offers warehouse management systems and consulting services.
Levit
Series A in 2022
Mobile commerce app that allows customers to have an enjoyable and affordable shopping experience
Agilis Robotics
Series A in 2022
Agilis Robotics is a developer of flexible robotic instruments for endoluminal surgery. They provide clinicians with enhanced robotic dexterity and precision while leveraging current clinical workflows.
Aloha Factory
Series A in 2022
Aloha Factory develops hyper-casual games, that are easy and intuitive, so anyone can play them.
Interior Teacher
Series A in 2022
Interior Teacher is a premium home styling service that specializes in interior decoration. The company offers a range of services, including design consultation, furniture recommendation, and delivery installation, aimed at creating functional and aesthetically pleasing spaces. Utilizing advanced AI technology, Interior Teacher provides clients with quick design drafts, simplifying the process of decorating their entire homes. This innovative approach enhances the customer experience by making home styling accessible and efficient.
NEW ID
Series A in 2022
New ID is a digital content platform specializing in content management systems, channel publishing, and artificial intelligence solutions. As a media company focused on the FAST (free ad-supported streaming TV) and AVOD (advertising-based video on demand) sectors, New ID serves as a technology partner for leading television manufacturers. The company has developed a connected TV platform that utilizes its proprietary technology to distribute channels globally. This enables clients to enhance their brand awareness through effective media strategies. Additionally, New ID operates a media research institute that fosters connections between consumers and the digital landscape, further solidifying its role in the evolving media ecosystem.
NeuReality
Series A in 2022
NeuReality is a semiconductor start-up focused on creating AI-as-a-service infrastructure to meet the demands of AI deployment across cloud, edge, and fog systems. The company specializes in purpose-built AI-centric architecture, offering a server-on-chip solution that reconfigures inference technologies like computer vision, natural language processing, and recommendation engines. This innovative approach simplifies the implementation of these technologies for companies that may lack extensive technical expertise. By replacing traditional CPU-centric models with its advanced architecture, NeuReality enables clients to reduce both costs and energy consumption, making AI more accessible and efficient for a broader range of users.
WE-AR
Series A in 2022
WE-AR is a creative studio focused on producing augmented reality (AR) content for major social media platforms. The company aims to assist brands in achieving their marketing objectives by addressing market challenges through innovative solutions. By collaborating with advertising planners, brand designers, 3D designers, and AR developers, WE-AR enhances the brand communication process, ultimately leading to more effective engagement strategies.
Robo Arete
Series A in 2022
Robo Arete is a robotics company specializing in the Food and Beverage (F&B) industry, established with the goal of innovating humanity's culinary culture and F&B business through the Robotics Kitchen. Comprising experts in robotics who directly execute development, deisgn, programming, and assembly of robotics automation systems, the team possess a comprehensive understanding of robotics. As a first project, we developed a robotics system equipped with the capability to automatically fry a variety of menu items, ranging from chicken to French fries. Since 2020, we have been operating our own chicken brand, "Robert Chicken," testing and continously enhancing the system in diverse environmnets, including delivery-focused stores, restaurants with dine-in options, shared kitchens, food trucks and others. The Robo Arete frying robot solution has been successfully implemented in various brands, including GS25, BHC, Hangry Joe's Hot Chicken, and ORG. The Robert Chicken familiy is expanding not only in South Korea but also in several countries. Franchise stores of Robert Chicken are set to open in the United States, Mexico, the Philippines, Singapore, and other countries in the first half of 2024, as part of an active pursuit of global market expansion. Robo Arete is also in the process of developing automation solutions for various cooking processes beyond frying, including hamburger patties and noodles. Additionally, we have developed robotic bartender for soju cocktails, currently being installed at the flagship Robert Chicken store in New York, with plans for public unveiling in the first half of 2024.
Monday OFF
Series A in 2022
Monday OFF is a mobile game developer and publisher located in South Korea.
Atoplex
Series A in 2022
Atoplex is a home test system and diagnosis platform using molecular immunodiagnosis technology.
Recon Labs
Series A in 2022
RECON Labs is a developer of a cloud-based artificial intelligence platform that specializes in converting two-dimensional photographs into three-dimensional models. This innovative technology utilizes virtual reality to automate the transformation of images, creating a new shopping experience for both customers and merchants. By enhancing the online commerce landscape, RECON Labs aims to improve customer satisfaction and drive sales growth.
Glorang
Series A in 2022
Glorang operates Korea's leading real-time online class platform for K-12 education, known as GGuge. The company has established itself as a dominant force in the assessment and psychology test market, capturing 80% of this sector in Korea. It focuses on addressing the limitations of traditional public and private education systems by offering a platform staffed by experienced teachers who provide high-quality education. Glorang also keeps educators informed about the latest trends and developments in education, ensuring that teaching methods remain relevant and effective. Recently, the company secured Series A2 funding, raising its total capital to approximately $20 million, and is expanding its presence in the APAC market with the launch of a global AI diagnostic solution, positioning itself as a leader in the AI Ed-Tech space.
Mighty Jaxx
Series A in 2022
Mighty Jaxx is an integrated future culture platform that specializes in designing and producing digital and physical collectibles. The company collaborates with renowned artists and global brands, including Netflix, Formula 1, and Hasbro, to create high-quality collectible art figures and toys. Through these partnerships, Mighty Jaxx delivers a diverse range of innovative products, shipping millions of collectibles annually to over 80 countries. The company's focus on exceptional artistry and collaboration positions it as a leader in the collectibles market, appealing to collectors seeking unique and exciting designs.
Geneos Therapeutics
Series A in 2022
Geneos Therapeutics, Inc. is focused on producing and developing neoantigen-targeting cancer immunotherapies. Founded in 2016 and headquartered in Plymouth Meeting, Pennsylvania, the company utilizes its Geneos Platform to create personalized therapies that are tailored to the unique tumor mutations of each patient. This innovative approach involves identifying relevant neoantigen targets from individual tumors, allowing for the development of novel treatments aimed at providing targeted immunotherapies for various types of cancer. By offering these customized solutions, Geneos seeks to enhance the effectiveness of cancer treatment and improve outcomes for patients.
Fast Forward
Series A in 2022
Fast Forward is an app development company that operates DOMINO, an investment management app.
Fanding
Series A in 2022
Fanding is a fan membership platform designed to facilitate interactions between content creators and their fans. The platform enables celebrities to establish and nurture their fan communities through a monthly subscription model. By offering private community services, Fanding allows fans to directly support their favorite creators, fostering a closer connection between them. The platform serves as a space for exclusive content and engagement, enhancing the overall experience for both creators and their supporters.
Whatssub
Series A in 2022
Whatssub is a company that specializes in developing a subscription management platform aimed at helping consumers manage their spending effectively. The platform allows users to oversee various subscription services, including telephone bills, savings, and loan repayments. By providing these tools, Whatssub empowers individuals to take control of their financial commitments and manage their subscriptions in a practical manner.
Loco
Series A in 2022
Loco is an Indian game streaming platform that focuses on creating multiplayer social communities for gamers. It allows users to connect with the public through live streams and arcade games, providing a space for players to showcase their skills. The platform is designed to enhance the gaming experience by enabling interaction with audiences and offering gameplay rewards, thereby maximizing engagement within the global gaming industry.
Mighty Jaxx
Series A in 2022
Mighty Jaxx is an integrated future culture platform that specializes in designing and producing digital and physical collectibles. The company collaborates with renowned artists and global brands, including Netflix, Formula 1, and Hasbro, to create high-quality collectible art figures and toys. Through these partnerships, Mighty Jaxx delivers a diverse range of innovative products, shipping millions of collectibles annually to over 80 countries. The company's focus on exceptional artistry and collaboration positions it as a leader in the collectibles market, appealing to collectors seeking unique and exciting designs.
Bifrost
Series A in 2022
Bifrost is a full developer suite for multichain DApp development, liberating blockchain developers from currently constrained infrastructure for specific blockchain networks.
HITS
Series A in 2022
HITS is a biotech company that creates digital solutions to accelerate drug development and introduce a new drug discovery paradigm. The company creates a cloud-based drug development platform that connects AI models with docking and molecular dynamics.
Doosan Robotics
Venture Round in 2022
Doosan Robotics is a company specializing in the manufacturing of collaborative robots, or cobots, which are designed to work safely alongside humans in various industrial settings. The company aims to overcome the limitations of traditional industrial robots, which can be risky, complex to operate, and expensive. Doosan Robotics provides a comprehensive suite of services, including manuals, technical data, training materials, and partner support, essential for building effective robotic systems. With a focus on innovation and engineering excellence, the company offers industry-leading technology that enhances user experience and operational efficiency. Its products are utilized in diverse applications globally, reflecting Doosan Robotics' commitment to driving growth and innovation within the robotics industry.
One Curegen
Series A in 2021
One Curegen develops diagnostic anti-cancer drugs.
Limbix
Series A in 2021
Limbix is a prescription digital therapeutic company focused on developing mental health treatments specifically for adolescents. The company combines clinical expertise with technological innovation, leveraging a diverse team of clinicians, product designers, researchers, and engineers to create effective therapeutic solutions. Limbix's flagship product, SparkRx, is a digital therapeutic designed to assist licensed healthcare professionals in treating young patients dealing with depression, anxiety, and other mental health issues. By offering evidence-based interventions, Limbix aims to enhance the lives of teenagers facing mental health challenges.
I-Sense
Series A in 2021
I-Sense is the development and manufacturing of bio-related sensors and analyzers.
Getcha
Series A in 2021
Getcha operates as a comprehensive online platform for car purchasing, long-term rentals, leasing, test rides, and car consulting. The company connects buyers with sellers through a comparison shopping service, allowing consumers to access a network of dealerships and obtain multiple price quotes. This transparency in transaction pricing empowers consumers to make informed decisions while enabling sellers to concentrate on potential buyers. By streamlining the car buying and renting process, Getcha aims to enhance the overall experience for both consumers and sellers in the automotive market.
Genedit
Series A in 2021
GenEdit Inc., founded in 2016 and based in Berkeley, California, focuses on advancing gene therapy through its innovative genome editing tools, particularly the CRISPR/Cas9 system. The company aims to address the challenges associated with gene therapy delivery by utilizing its proprietary NanoGalaxy™ platform, which systematically screens a library of nanoparticles to enhance the safety and efficiency of delivering genetic material to target tissues. GenEdit's technology is designed to facilitate therapeutic gene editing, offering a solution that is easier, faster, and more accurate than traditional methods. This positions GenEdit to potentially enable the treatment of previously incurable genetic diseases, significantly contributing to the future of non-viral, gene editing-based therapeutics.
Autonomous a2z
Series A in 2021
Autonomous a2z Co., Ltd. is a South Korean company that specializes in the development and operation of artificial intelligence-based autonomous driving solutions. Founded in 2018 and headquartered in Gyeongsan-si, with additional offices in Anyang-si and Sejong City, the company focuses on providing a comprehensive driving mobility platform. Its technology encompasses recognition of surrounding conditions, determination of driving strategies, and automatic vehicle control. By offering advanced algorithms for vehicles, Autonomous a2z enables the commercialization of specialized vehicles, including cleaning trucks, container trucks, and tractors. The company's solutions are designed to enhance the safety and efficiency of autonomous driving across various applications within Korea.
Breezytail
Series A in 2021
Breezytail is a pet service company that specializes in pet lifestyle products, focusing on enhancing pet health care. The company provides a diverse range of offerings, including face care, hair care, and bath products, as well as household goods designed for pets. By prioritizing the well-being of pets, Breezytail aims to help them live longer and healthier lives through its carefully developed product line.
Athena's Lab
Series A in 2021
Athena’s Lab is a lifestyle and education technology company that improves student daily life to be an effortless experience as a useful friend in their journey throughout K12. One of the company’s main services, ‘TodaySchool’, a student lifestyle platform, enables its users to easily get access to essential information regarding their school and education. By simply entering only their school and class, users get access to their timetable, cafeteria menu, extracurricular academies, in-app community, and many more. Around one million users have joined in. The company’s other services are ‘Prompie’ and ‘Prompie Academy’, which connects tutors and extracurricular academies with consumers. ‘Prompie’ currently has 110K tutors and ‘Prompie Academy’ has the most amount of academy reviews and ratings in Korea. The company has raised $3 million from seven investors including Korea Investment Partners (KIP), Stonebridge Ventures, Schmidt, Industrial Bank of Korea, Banks Foundation for Young Entrepreneurs (D-Camp), Korea Credit Guarantee Fund (KODIT).
Tcino Bioscience
Series A in 2021
Tcino Bioscience develops molecule anti-cancer drugs for cancer patients.
SodaGift
Venture Round in 2021
SodaGift is an international gifting service that simplifies the process of sending gifts, particularly gift cards, across borders. The platform enables users to purchase and present gift cards from popular brands in the United States, South Korea, and Canada. By providing a seamless user experience and supporting multiple languages, SodaGift facilitates easy transactions and real-time transmission of gifts, allowing individuals living abroad to send thoughtful presents to their families back home.
Mighty Jaxx
Series A in 2021
Mighty Jaxx is an integrated future culture platform that specializes in designing and producing digital and physical collectibles. The company collaborates with renowned artists and global brands, including Netflix, Formula 1, and Hasbro, to create high-quality collectible art figures and toys. Through these partnerships, Mighty Jaxx delivers a diverse range of innovative products, shipping millions of collectibles annually to over 80 countries. The company's focus on exceptional artistry and collaboration positions it as a leader in the collectibles market, appealing to collectors seeking unique and exciting designs.
21gram
Series A in 2021
21gram is a provider of pet funeral services that connects pet owners with reputable companion animal funeral homes. The company offers an online platform where customers can search for funeral homes based on their location, budget, and specific service needs. In addition to facilitating bookings, 21gram provides counseling services to help pet owners navigate the emotional process of saying goodbye to their pets. By focusing on both practical arrangements and emotional support, 21gram aims to ensure that pet owners can honor their beloved companions with dignity and care.
S-Alpha Therapeutics
Series A in 2021
S-Alpha Therapeutics Inc. is a digital therapeutics company based in Seoul, South Korea, founded in 2019. It focuses on researching and developing health applications and platform technologies designed to treat various diseases through digital devices. The company's product lineup includes SAT-001 for ophthalmology, SAT-002 for neurology, SAT-003 for oncology, and SAT-008 for addressing social issues. In addition to these applications, S-Alpha Therapeutics is engaged in developing therapeutic devices aimed at providing innovative treatment solutions for conditions that are challenging to address with existing medical technologies. The company strives to create a healthier and more equitable society by leveraging the intersection of biology and information technology to meet unmet medical needs.
MAXVAX
Series A in 2021
MAXVAX is focused on the development and commercialization of innovative vaccines, specifically targeting viral diseases such as rotavirus, shingles, and herpes. The company's technology is designed to enhance treatment options within the biotechnology industry, enabling healthcare professionals to offer improved solutions for patients suffering from these infections. By concentrating on effective vaccine development, MAXVAX aims to contribute significantly to the healthcare sector and improve patient outcomes.
TSD Life Sciences
Series A in 2021
TSD Life Sciences Co., Ltd., established in 2016 and based in Seoul, South Korea, specializes in the research and development of pharmaceuticals aimed at treating rare and intractable diseases, particularly cancer. The company offers a range of clinical research services, including non-clinical and clinical operations, project management, and support for orphan drug designation. TSD Life Sciences focuses on developing antibody drugs that address incurable diseases, thereby empowering healthcare professionals to effectively treat patients with rare conditions.
VSI
Series A in 2021
VSI specializes in developing semiconductors and networking solutions tailored for the automotive and industrial sectors. The company focuses on automotive networking technologies, producing essential components for next-generation vehicles, including autonomous models. By providing innovative semiconductor products, VSI supports car manufacturers in enhancing vehicle connectivity and functionality.
Jaranda
Series A in 2021
Jaranda is a platform designed to support working parents by providing educational services for children. It addresses the challenges of accessing reliable childcare and education information, which often relies on personal networks. The platform connects parents, teachers, and students, utilizing analytics to match students with appropriate educators. Additionally, Jaranda offers regular visit services and lifecycle management, ensuring that children and pre-teens receive the necessary educational support in a convenient and efficient manner. This approach helps families discover and engage with educational opportunities tailored to their needs.
IR KUDOS
Series A in 2021
IR KUDOS is a consulting agency that offers IPR, IPO, and strategic consulting services.
Spendit
Series A in 2021
Spendit is a B2B fintech company in Seoul, Korea.
Inflearn
Series A in 2021
Inflearn is an online learning platform focused on sharing and teaching IT knowledge. It connects students with expert instructors who offer lectures on a variety of topics, including Python and data analytics. This brokerage platform facilitates knowledge exchange, allowing learners to access valuable insights and expertise from professionals in the IT field. By providing a space for both teaching and learning, Inflearn aims to enhance the educational experience and foster skill development in technology-related areas.
Guhada
Series A in 2021
Guhada operates an online retail platform that serves as a distribution hub for luxury goods, connecting local boutiques in Europe with domestic shopping malls and the broader luxury fashion market. The platform specializes in high-demand luxury items and contemporary fashion products, offering a diverse range of bags, clothing, shoes, and accessories for both men and women. Utilizing a blockchain-based e-commerce system, Guhada ensures the authenticity of its products while providing customers with access to genuine luxury goods at competitive prices. This innovative approach enables the company to meet the growing demand for quality fashion items in the domestic market.
Geneos Therapeutics
Series A in 2021
Geneos Therapeutics, Inc. is focused on producing and developing neoantigen-targeting cancer immunotherapies. Founded in 2016 and headquartered in Plymouth Meeting, Pennsylvania, the company utilizes its Geneos Platform to create personalized therapies that are tailored to the unique tumor mutations of each patient. This innovative approach involves identifying relevant neoantigen targets from individual tumors, allowing for the development of novel treatments aimed at providing targeted immunotherapies for various types of cancer. By offering these customized solutions, Geneos seeks to enhance the effectiveness of cancer treatment and improve outcomes for patients.
Yibai Technology
Series A in 2020
Yibai Technology is a specialist in healthcare-based software-as-a-service.
DoctorHere
Series A in 2020
DoctorHere is a smart medical clinic using AI and IT to provide primary care both in-person and virtually
EvidNet
Series A in 2020
EvidNet is a healthcare IT company focused on providing Real World Evidence (RWE) solutions derived from hospital data, aimed at enhancing research and business decision-making within the life sciences and healthcare sectors. Collaborating with over 50 university and general hospitals in Korea, EvidNet builds Real World Data (RWD) following the OMOP-CDM standard. Their FeederNet® data platform supports multi-institutional research and AI federated machine learning while ensuring privacy and security. The company specializes in managing clinical practice data through an interoperable, real-time integrated healthcare data network, offering tailored statistical analysis that meets the specific needs of hospitals and clients. By leveraging these advanced technologies, EvidNet delivers valuable insights that span from research and development to commercialization, ultimately contributing to the advancement of precision and predictive medicine.
Santa
Series A in 2020
Santa is pushing content creation to new limits. Didicast, an easy to use video editing software developed by Santa, is made for content creators that are determined to produce polished videos for anything from education to entertainment. By leveling the learning curve and throwing out the expenses required in traditional content creation, Santa is helping creators from around the world change the world.
Trost
Series A in 2020
Trost, operated by Humart Company Co., Ltd., specializes in mental healthcare services, offering a range of online counseling options. Founded in 2016 and headquartered in Seoul, South Korea, Trost utilizes a mobile application to facilitate consultations between users and licensed counselors, enabling effective diagnosis and treatment. In addition to counseling, the platform provides various self-analysis tests, including psychological assessments, personality evaluations, and stress-related tests. Through its employee assistance program, Trost aims to enhance mental well-being in both individual and workplace settings.
Saige Research
Series A in 2020
Saige Research is a company that focuses on providing artificial intelligence solutions specifically for the manufacturing sector, particularly in the area of industrial inspection and quality control. The firm has developed a deep learning vision inspection platform that addresses the challenges faced by inspectors, enhancing work efficiency. This technology offers capabilities such as power detection, speed detection, and versatility, allowing for greater convenience in development. By automating the inspection process, Saige Research aims to deliver optimal AI solutions that improve quality assurance in manufacturing environments.
Immunobiome
Series A in 2020
Immunobiome focuses on developing microbiome-targeted therapeutics aimed at treating challenging conditions such as cancer, autoimmune diseases, and neurological disorders. The company leverages advanced immunology, bioinformatics, and foundational microbiome research to create innovative healthcare solutions. Their platform addresses a range of health issues, including intractable immune disorders, allergies, organ transplant rejections, and diabetes-related inflammation. By targeting the microbiome, Immunobiome seeks to provide effective treatment options for patients suffering from these complex diseases.
Mepsgen
Series A in 2020
Mepsgen is a biotechnology research organization that focuses on pharmaceutical services and drug development.
Zamface
Series A in 2020
Zamface is operated by Zackdang Company and serves as a beauty video application designed to assist users in analyzing cosmetics and their compatibility with individual skin types. The platform offers features such as personal color diagnosis, makeup tutorials, and product reviews, along with recommendations from beauty influencers. By providing these resources, Zamface aims to help users select beauty products that complement their unique coloring and preferences.
Connecting
Series A in 2020
Connecting is a company that offers a real-time voice-talk service designed to facilitate meaningful conversations between individuals. Its application enables users to specify their preferences, such as hobbies, age, region, and gender, which are then matched through an algorithm tailored to enhance user experience. By providing a platform that connects people with shared interests, Connecting aims to promote engaging dialogues and foster connections in a straightforward manner.
Haoxinqing
Series A in 2020
Haoxinqing is an online medical service platform specializing in mental psychology and chronic disease management. The platform offers users remote diagnosis and treatment services, allowing patients to access medical care conveniently from their homes. By focusing on these areas, Haoxinqing aims to improve the accessibility and quality of healthcare for individuals dealing with mental health issues and chronic conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.